CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation

52Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE. Percutaneous thermal ablation is an emerging technique in the management of renal cell carcinoma (RCC), with greatest efficacy in tumors ≤ 3 cm. The purpose of this retrospective study was to evaluate the role and utility of pretreatment CT-guided biopsy in patients referred for percutaneous thermal ablation of renal tumors. CONCLUSION. Less than 5% of samples in our study were benign, and 11.8% were non-diagnostic. Biopsy in smaller lesions was less accurate; therefore biopsy is less useful for these renal lesions. Because fine-needle aspiration (FNA) has higher sensitivity than core biopsy, an appropriate algorithm may be to begin with FNA and reserve core biopsy for cases in which an onsite cytotechnologist is unavailable or deems the sample of inadequate cellularity. © American Roentgen Ray Society.

Cite

CITATION STYLE

APA

Heilbrun, M. E., Zagoria, R. J., Garvin, A. J., Hall, M. C., Krehbiel, K., Southwick, A., & Clark, P. E. (2007). CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. American Journal of Roentgenology, 188(6), 1500–1505. https://doi.org/10.2214/AJR.06.0389

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free